NL-OMON23804招募中不适用
A pharmacokinetic study to assess age-related and intra-patient differences in the pharmacokinetics of intravenous pegylated liposomal doxorubicin in female cancer patients.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 34
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •2. Solid tumour;
排除标准
- •1. Evidence of metastases in the central nervous system, unless previously treated and being asymptomatic/controlled for at least 3 months;
- •2. History of cardiac disease, with NYHA Class II or greater, or clinical evidence of congestive heart failure or myocardial infarction within less than six months;
研究者
相似试验
已完成
1 期
A Study of Lasmiditan in Healthy ParticipantsHealthyNCT03182920Eli Lilly and Company35
终止
1 期
AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine TherapyBreast CancerNCT03092635Medical University of South Carolina9
已完成
1 期
A Pharmacokinetics Study of MultiHance in Pediatric PatientsCentral Nervous System PathologyNCT00411931Bracco Diagnostics, Inc15
已完成
2 期
The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)Essential ThrombocythaemiaNCT00413634Shire24
终止
1 期
Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058Pulmonary Arterial HypertensionNCT04991194Bial - Portela C S.A.61